Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04129567 · ClinicalTrials.gov registry record · NA
Transnasal Therapy for Acute Migraine Attack
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 51
- Enrollment target
NCT04129567: Completed NA study, sponsored by Johns Hopkins University.
NCT04129567 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 51 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04129567, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
Study Summary
Migraine is a significant health problem in the United States with 34 million Americans suffering from migraine attacks every year. High-flow oxygen has been successfully used in several clinical studies. Vasoconstriction of blood vessels in the scalp has been proposed as a possible mechanism of action. Some researchers have suggested that the cooling effect of high-flow dry oxygen may be in part responsible for the pain relief. The main objective is to test the hypothesis that the pain relief obtained during high-flow trans-nasal gas therapy is due to the cooling effect of dry gas on the nasal mucosa. The study entails recruiting patients from a headache clinic, being escorted to the Institute for Clinical and Translational Research (ICTR) Johns Hopkins Bayview and randomized into different groups (humidified oxygen, dry air, humidified air and dry oxygen). Eventually, patients will be asked to fill out a questionnaire on pain, nausea, sound and light sensitivity graded on a scale of 1-10. Readings are noted at baseline, 15 mins, 2 hours and 24 hours post-therapy.
Interventions
- OTHER Humidified oxygen
- OTHER Dry oxygen
- OTHER Humidified air
- OTHER Dry air
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2018-08-15 |
| Est. Completion | 2019-11-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04129567
The ClinicalTrials.gov registry entry for NCT04129567 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Humidified oxygen is the first listed.
NCT04129567 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04129567 about?
NCT04129567 is a clinical study titled "Transnasal Therapy for Acute Migraine Attack". Migraine is a significant health problem in the United States with 34 million Americans suffering from migraine attacks every year. High-flow oxygen has been successfully used in several clinical studies. Vasoconstriction of blood vessels in the scalp has been proposed as a possible mechanism of act...
What is the current status of trial NCT04129567?
This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2018-08-15. Estimated completion is 2019-11-15.
What interventions are being tested in trial NCT04129567?
The interventions under investigation include: Humidified oxygen (OTHER), Dry oxygen (OTHER), Humidified air (OTHER), Dry air (OTHER).
Who is sponsoring clinical trial NCT04129567?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.